Chargement en cours...
Synthesis, biological activity and molecular docking of new tricyclic series as α-glucosidase inhibitors
Diabetes is an emerging metabolic disorder. α-Glucosidase inhibitors, such as acarbose, delay the hydrolysis of carbohydrates by interfering with the digestive enzymes. This action decreases the glucose absorption and the postprandial glucose level. We have synthesized 25 tricyclic 2-phenoxypyrido[3...
Enregistré dans:
| Publié dans: | BMC Chem |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer International Publishing
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6661812/ https://ncbi.nlm.nih.gov/pubmed/31384800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13065-019-0560-4 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|